WASF3-AS1

Across TCGA pan-cancer cohorts, WASF3-AS1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of WASF3-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where WASF3-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types WASF3-AS1 is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

THCA, HNSC, and BRCA are the cancer types where WASF3-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in WASF3-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.029	.005	4	view →
HNSC	All	All	+0.026	.024	4	view →
BRCA	All	III,IV	−0.043	.004	2	view →
KIRC	Male	All	+0.006	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

WASF3-AS1–THCA

Open the THCA breakdown →